Evidence map›Paper›PMID 33760164›Full record

ArticleMolecular medicine reports2021

miR-93-5p promotes insulin resistance to regulate type 2 diabetes progression in HepG2 cells by targeting HGF.

Man Zhou, Yilin Hou, Jun Wu, Guangli Li, Ping Cao, Wan Chen, Lingli Hu, Dingyun Gan

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. CircRNA-SCAF8 promotes vascular endothelial cell pyroptosis by regulating the miR-93-5p/TXNIP axis.Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2023
    Article
  8. Article
  9. British journal of biomedical science · 2023
    Article
  10. Experimental Approaches to Diabetes Mellitus.The Eurasian journal of medicine · 2022
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Man ZhouDepartment of Endocrinology, Wuhan Third Hospital, Wuhan, Hubei 430060, P.R. China.
Yilin HouDepartment of Endocrinology, Wuhan Third Hospital, Wuhan, Hubei 430060, P.R. China.
Jun WuDepartment of Endocrinology, Wuhan Third Hospital, Wuhan, Hubei 430060, P.R. China.
Guangli LiDepartment of Endocrinology, Wuhan Third Hospital, Wuhan, Hubei 430060, P.R. China.
Ping CaoDepartment of Endocrinology, Wuhan Third Hospital, Wuhan, Hubei 430060, P.R. China.
Wan ChenDepartment of Endocrinology, Wuhan Third Hospital, Wuhan, Hubei 430060, P.R. China.
Lingli HuDepartment of Endocrinology, Wuhan Third Hospital, Wuhan, Hubei 430060, P.R. China.
Dingyun GanDepartment of Endocrinology, Wuhan Third Hospital, Wuhan, Hubei 430060, P.R. China.
Wuhan Third Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insulin resistance is a common feature of type 2 diabetes mellitus (T2DM). However, the mechanisms underlying insulin resistance are not completely understood. The present study aimed to investigate the effect of microRNA (miR)‑93‑5p on insulin resistance in T2DM cells. Human hepatocellular carcinoma (HCC; HepG2) cells were cultured in medium with high glucose content (30 mM glucose) to establish an

Indexed as

ApoptosisCarcinoma, HepatocellularCell Line, TumorCell ProliferationCell SurvivalDiabetes Mellitus, Type 2Gene Expression Regulation, NeoplasticGlucoseHepatocyte Growth FactorHep G2 CellsHumansInsulinInsulin ResistanceLiver NeoplasmsMicroRNAsGlucoseHepatocyte Growth FactorHGF protein, humanInsulinMicroRNAsMIRN93 microRNA, humanhepatocyte growth factorinsulin resistancemicroRNA-93-5ptype 2 diabetes

Identifiers

PMID33760164
PMCPMC7974269
OpenAlexW3133493613

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.